A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs

Objective: To examine the health care costs associated with ADHD within a nationally representative sample of children. Method: Data were from Waves 1 to 3 (4-9 years) of the Longitudinal Study of Australian Children ( N = 4,983). ADHD was defined by previous diagnosis and a measure of ADHD symptoms (Strengths and Difficulties Questionnaire [SDQ]). Participant data were linked to administrative data on health care costs. Analyses controlled for demographic factors and internalizing and externalizing comorbidities. Results: Costs associated with health care attendances and medications were higher for children with parent-reported ADHD at each age. Cost differences were highest at 8 to 9 years for both health care attendances and medications. Persistent symptoms were associated with higher costs ( p < .001). Excess population health care costs amounted to Aus$25 to Aus$30 million over 6 years, from 4 to 9 years of age. Conclusion: ADHD is associated with significant health care costs from early in life. Understanding the costs associated with ADHD is an important first step in helping to plan for service-system changes.

Download Full-text

Can Persistence With Cholinesterase Inhibitor Treatment Lower Mortality and Health-Care Costs Among Patients With Alzheimer’s Disease? A Population-Based Study in Taiwan

American Journal of Alzheimer s Disease & Other Dementias® ◽

10.1177/1533317517734639 ◽

2017 ◽

Vol 33 (2) ◽

pp. 86-92 ◽

Cited By ~ 5

Author(s):

Li-Jung Elizabeth Ku ◽

Chung-Yi Li ◽

Yu Sun

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Health Care ◽

Health Care Costs ◽

Cholinesterase Inhibitor ◽

Population Based ◽

Lower Mortality ◽

Population Based Study ◽

Care Costs ◽

Inhibitor Treatment

Download Full-text

Cyclic Vomiting Syndrome-Related Hospitalizations Trends, Comorbidities & Health Care Costs in Children: A Population Based Study

Children ◽

10.3390/children9010055 ◽

2022 ◽

Vol 9 (1) ◽

pp. 55

Author(s):

Aravind Thavamani ◽

Krishna Kishore Umapathi ◽

Jasmine Khatana ◽

Sanjay Bhandari ◽

Katja Kovacic ◽

...

Keyword(s):

Health Care ◽

Resource Utilization ◽

Health Care Costs ◽

Population Based ◽

Primary Diagnosis ◽

Healthcare Resource Utilization ◽

Cannabis Use ◽

Cyclic Vomiting Syndrome ◽

Hospitalization Costs ◽

Care Costs

Aim: To analyze the clinical characteristics, trends in hospitalization and health care resource utilization of pediatric patients with cyclical vomiting syndrome (CVS). Methods: We analyzed the latest 5 Healthcare Cost and Utilization Project-Kids Inpatient Database (HCUP-KID) datasets including years 2003, 2006, 2009, 2012 and 2016 for patients aged 1–20 years with a primary diagnosis of CVS and were compared with Age/gender-matched controls for comorbidities, clinical outcomes, and healthcare resource utilization. Results: A total of 12,396 CVS-related hospitalizations were analyzed. The mean age of CVS patients was 10.4 ± 6.7 years. CVS was associated with dysautonomia (OR: 12.1; CI: 7.0 to 20.8), dyspepsia (OR: 11.9; CI: 8.8 to 16.03), gastroesophageal reflux disease (OR: 6.9; Confidence Interval (CI): 6.4 to 7.5), migraine headaches (OR: 6.8; CI: 5.9 to 7.7) and irritable bowel syndrome (OR: 2.08; CI: 1.2 to 4.3) (all p < 0.001). CVS was also associated with increased cannabis use (OR: 5.26, 4.6 to 5.9; p < 0.001), anxiety disorder (OR: 3.9; CI: 3.5 to 4.4) and stress reaction (OR: 3.6; CI: 2.06 to 6.3), p < 0.001. Mean CVS-related hospitalization costs (inflation adjusted) more than doubled from $3199 in 2003 to $6721 in 2016, incurring $84 million/year in total costs. Conclusion: Hospitalized CVS patients have increased prevalence of DGBIs, dysautonomia, psychiatric conditions and cannabis use compared to non-CVS controls. CVS-related hospitalizations in U.S. is associated with increasing health care costs. Better management of CVS and comorbid conditions is warranted to reduce health care costs and improve outcomes.

Download Full-text

The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study

Diabetes Care ◽

10.2337/dc19-0573 ◽

2020 ◽

Vol 43 (4) ◽

pp. 751-758 ◽

Cited By ~ 4

Author(s):

Manel Mata-Cases ◽

Beatriz Rodríguez-Sánchez ◽

Dídac Mauricio ◽

Jordi Real ◽

Bogdan Vlacho ◽

...

Keyword(s):

Health Care ◽

Glycemic Control ◽

Health Care Costs ◽

Population Based ◽

Poor Glycemic Control ◽

Population Based Study ◽

Care Costs

Download Full-text

Health Care Costs Associated to Type of Feeding in the First Year of Life

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph17134719 ◽

2020 ◽

Vol 17 (13) ◽

pp. 4719

Author(s):

Carolina Lechosa-Muñiz ◽

María Paz-Zulueta ◽

María Sáez de Adana Herrero ◽

Elsa Cornejo del Rio ◽

Sonia Mateo Sota ◽

...

Keyword(s):

Primary Care ◽

Health Care ◽

Infectious Diseases ◽

Emergency Room ◽

Health Care Costs ◽

Medical Records ◽

Hospital Admissions ◽

First Year ◽

First Year Of Life ◽

Care Costs

Background: Breastfeeding is associated with lower risk of infectious diseases, leading to fewer hospital admissions and pediatrician consultations. It is cost saving for the health care system, however, it is not usually estimated from actual cohorts but via simulation studies. Methods: A cohort of 970 children was followed-up for twelve months. Data on mother characteristics, pregnancy, delivery and neonate characteristics were obtained from medical records. The type of neonate feeding at discharge, 2, 4, 6, 9 and 12 months of life was reported by the mothers. Infectious diseases diagnosed in the first year of life, hospital admissions, primary care and emergency room consultations and drug treatments were obtained from neonate medical records. Health care costs were attributed using public prices and All Patients Refined–Diagnosis Related Groups (APR–DRG) classification. Results: Health care costs in the first year of life were higher in children artificially fed than in those breastfed (1339.5€, 95% confidence interval (CI): 903.0–1775.0 for artificially fed vs. 443.5€, 95% CI: 193.7–694.0 for breastfed). The breakdown of costs also shows differences in primary care consultations (295.7€ for formula fed children vs. 197.9€ for breastfed children), emergency room consultations (260.1€ for artificially fed children vs. 196.2€ for breastfed children) and hospital admissions (791.6€ for artificially fed children vs. 86.9€ for breastfed children). Conclusions: Children artificially fed brought about more health care costs related to infectious diseases than those exclusively breastfed or mixed breastfed. Excess costs were caused in hospital admissions, primary care consultations, emergency room consultations and drug consumption.

Download Full-text